Verici Dx (LON:VRCI) Stock Price Up 4.4% – Here’s What Happened

Verici Dx plc (LON:VRCI) shot up 4.4% during mid-day trading on Thursday . The stock traded as high as GBX 2.48 ($0.03) and last traded at GBX 2.48 ($0.03). 215,225 shares traded hands during mid-day trading, a decline of 36% from the average session volume of 333,685 shares. The stock had previously closed at GBX 2.38 ($0.03).

Verici Dx Stock Up 4.4 %

The firm has a 50-day simple moving average of GBX 3.09 and a 200 day simple moving average of GBX 5.44. The company has a market capitalization of £6.01 million, a PE ratio of -124.00 and a beta of 1.59. The company has a debt-to-equity ratio of 4.65, a current ratio of 4.54 and a quick ratio of 8.49.

Verici Dx Company Profile

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.